SUBSCRIBE
SUBSCRIBE
News   Business

Merck & Co., Inc. Extends Deadline For Talks On Dutch Organon Closures

December 17, 2010 | 
1 min read
AMSTERDAM Dec 17 (Reuters) - U.S. drugmaker Merck & Co Inc (MRK.N) said on Friday it has further postponed the closure of some of its Dutch operations pending discussions about possible alternatives, including a sale of the R&D site.
Real estate Europe
Merck & Co.
MORE ON THIS TOPIC
Woman taking retro photos. Digital collage with female hands holding vintage camera. Pop art design. Concept of social media
Mergers & acquisitions
UCB captures Candid in $2.2B autoimmune deal as pharma’s M&A train chugs along
May 4, 2026
 · 
2 min read
 · 
Tristan Manalac
A surreal concept of a regular aluminium ladder pushing through a fluffy cloud on a peach sky background - 3D render
Obesity
Obesity ends oncology’s long reign as top contributor to biopharma pipeline value
May 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Photo of pinned Raleigh on a map of USA. May be used as illustration for traveling theme.
Manufacturing
Novartis unveils North Carolina API plant as final piece of $23B US expansion
May 1, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Court Filed Bankruptcy 3d illustration
Earnings
Moderna beats revenue expectations with $389M, but litigation dogs earnings
May 1, 2026
 · 
3 min read
 · 
Annalee Armstrong